DRUGS · API / EXCIPIENTS / PACKAGING

API, feed and pharmanatural collecting FDA compliance service

For pharmaceutical supply chain enterprises, the application requirements of API are checked separately from the intermediate, pharmaceuticents and pharmamediatical packaged to provide registration listing judgements, DMF technical documents, authorized references and ongoing maintenance support.

START HERE

Let's sort out the product, then choose the service.

  1. 01

    Identification of product and customer uses

    Provide material identification, intended use, production activities, customer requirements and access to related drugs.

  2. 02

    Reconciling obligations and information gaps

    Adjudication of the applicability of registered listings, DMF types, authorized references and research information, respectively.

  3. 03

    Scope of agreed submission and maintenance

    Confirm technical information, electronic format, delegation of authority, annual update and change communication responsibilities.

SERVICE DIRECTORY

Selection of specific services according to demand

The use of products, business activities and information is identified before the range of services is determined. The relevant services can be combined.

01

API with intermediates

(b) The application of a combination of material use, production activities and related pharmaceutical applications; API should not generalize the same obligations as intermediates.

API and intermediate DMF support

(b) To collate the technical information, document organization, authorized references and subsequent changes of the Type II DMF, as applicable; Type II API DMF, which supports ANDA, also has to check the application of GDUFA matters.

View service details
02

I'm sorry, I'm sorry.

To confirm the actual use of the supplement and the technical requirements of the customer; Not all supplements have to be submitted separately to the DMF.

03

I'm sorry, but I'm sorry.

Identify the range of services around technical information on intended packaging uses, material composition and pharmaceutical compatibility.

04

Technical submission and document maintenance

Determines the arrangements for electronic submission, authorization and maintenance based on the DMF type, linkage application and current FDA requirements.

D.U.N.S.

Assist in searching and checking D-U-N-S records of pharmaceutical facilities or related subjects, and press D&B Current process to sort requests or correct information; Reconnected with the registration and listing information of the FDA pharmaceutical facility. D-U-N-S by D-D-E-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-T-S-T-T-T-A-T-T-T-T-T-T-T-A-T-T-T-T-T-T-T-A-T-T-T-A-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-&B Management, not FDA approval or registration certificate.

View service details

The DMF type is a classification of technical information and is not a direct substitute for a judgement on the applicability of registered listings. (a) Complement and pharmaceutical listing are not always registered, NDC or listed as pharmaceutical formulations; The DMF submission, acceptance or numbering is also not equivalent to FDA approval or authentication.

ONGOING SUPPORT

Drug projects need to be continuously checked against product life cycle

Discuss record maintenance →
  • Maintenance of DMF contacts, holders, technical content and annual updates, as applicable, and timely processing of FDA communications.
  • Communicate with authorized quotes to apply the change and check the authorization to quote information and request association.
  • The API facility registration, product listing and applicable costs are checked separately and cannot be replaced by DMF maintenance.
BEFORE YOU DECIDE

You might care before you choose a pharmaceutical service.

Do APIs, supplements and pharmaceutical coverings have to be submitted to DMFs?

It cannot be said in general terms. The use of DDFs should be determined by reference to material nature, related drug applications, customer citation and confidential information arrangements; Customer requirements should not be directly referred to as a uniform statutory obligation for all enterprises.

How do the DMF categories II, III and IV correspond?

Type II includes API, intermediates, relevant preparation materials or pharmaceutical formulations; Type III is a packaging material; Type IV is a supplement, pigment, spice and its preparation material. The type should be selected in conjunction with the specific content and current FDA requirements.

Do you also have to apply for NCD?

NDC or listing processes that do not directly apply formulations by name of material. It should be judged by the intended use of the material, regulatory identity and entrepreneurial activity; Pure supplements and pharmaceutical packaging are not always treated as finished medicines.

Is getting DMF number approved?

No. DMF is the mechanism for providing confidential technical information to FDA, whose references and reviews need to be combined with relevant applications and should not be promoted for the approval of independent products or for DMF certification.

RELATED READING

Explore related rules and projects

Browse related guidance →
DEFINE YOUR NEXT STEP

Provide products and current information to confirm service application.

The use of materials, production activities, customer association applications and the existence of a DMF or other declaration record are confirmed first, and the specific service content and costs are subject to the mutually recognized scope of the project.